Hebei Hejia Pharmatech Group is a strong player devoted to R&D of cephalosporin, APIs & intermediates in China. After 14 years' operation, we emerged in APIs industry via the merging of Sinopharm Baida Pharmaceutical. With approval of GMP authentication, we are now preparing for COS with estimated completion time 2016.

Sales Markets

Middle East Region (e.g. UAE); Oceania; North America (USA, Canada); Africa; Central America (e.g. Mexico); East Asia (e.g. China, Japan, Korea); Europe - EU countries; Europe - non EU (e.g. UK, Russia, ex-CIS countries); South America (e.g. Brazil, Colombia); South Asia (e.g. India, Pakistan, Sri Lanka); South East Asia (e.g. Thailand, Philippines, Singapore)

Primary business activity

Manufacturer/Innovator

Contact information

Address

Telephone

Website

View All Contact Info

Top Products

MAEM

MAEM

Hebei Hejia Pharmatech Group Co Ltd